The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients

International Journal of Rheumatic Diseases

Volumn 14, Issue 1, 2011, Pages 12-17

  Gomez, Edmund Luke ^a   Gun, Suk Chyn ^b   Somnath, Sushela Devi ^a   D'souza, Beryl ^b   Lim, Ai Lee ^b   Chinna, Karuthan ^c   Radhakrishnan, Ammu K ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b Hospital Tuanku Ja'afar   (Malaysia)

^c UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Anti cyclic citrullinated peptides; Auto antibodies; Rheumatoid arthritis; Rheumatoid factor; Rheumatoid factor isotypes

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGE; ARTICLE; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INDIAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; ONSET AGE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROPREVALENCE;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CHINA; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; INDIA; MALAYSIA; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 79551707302     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01573.x     Document Type: Article

References (20)

1. Waaler E (2007) On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. 1939. APMIS 115, 422-38; discussion 439.
2. Franklin EC, Holman HR, Muller-Eberhard HJ, Kunkel HG (1957) An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med 105, 425-38.
3. Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-24.
4. Goldbach-Mansky R, Lee J, McCoy A, et al. (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2, 236-43.
5. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47, 1089-93.
6. Fabien N, Olsson NO, Goetz J, et al. (2008) Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: a French multicenter study. Clin Rev Allergy Immunol 34, 40-4.
7. Schellekens GA, Visser H, de Jong BA, et al. (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43, 155-63.
8. Nishimura K, Sugiyama D, Kogata Y, et al. (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146, 797-808.
9. Saraux A, Berthelot JM, Devauchelle V, et al. (2003) Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol 30, 2535-9.
10. Nielen MM, van Schaardenburg D, Reesink HW, et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50, 380-6.
11. Quinn MA, Gough AK, Green MJ, et al. (2006) Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford) 45, 478-80.
12. van Gaalen FA, Visser H, Huizinga TWJ (2005) A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis 64, 1510-2.
13. Vanichapuntu M, Phuekfon P, Suwannalai P, Verasertniyom O, Nantiruj K, Janwityanujit S (2009) Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population? Rheumatol Int 30, 755-59.
14. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48, 2741-9.
15. Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63, 1079-84.
16. Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 42, 677-80.
17. Mattey DL, Dawes PT, Clarke S, et al. (2002) Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum 47, 403-7.
18. Irigoyen P, Lee AT, Wener MH, et al. (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 52, 3813-8.
19. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171, 538-41.
20. Ursum J, Bos W, van de Stadt R, Dijkmans B, van Schaardenburg D (2009) Different properties of antibodies to citrullinated proteins/peptides and IgM rheumatoid factor derived from a large dataset: further evidence of two distinct autoantibody systems. Arthritis Res Ther 11, R75.